» Articles » PMID: 20194595

Inactivation of Phospholipase D Diminishes Acinetobacter Baumannii Pathogenesis

Overview
Journal Infect Immun
Date 2010 Mar 3
PMID 20194595
Citations 121
Authors
Affiliations
Soon will be listed here.
Abstract

Acinetobacter baumannii is an emerging bacterial pathogen of considerable health care concern. Nonetheless, relatively little is known about the organism's virulence factors or their regulatory networks. Septicemia and ventilator-associated pneumonia are two of the more severe forms of A. baumannii disease. To identify virulence factors that may contribute to these disease processes, genetically diverse A. baumannii clinical isolates were evaluated for the ability to proliferate in human serum. A transposon mutant library was created in a strain background that propagated well in serum and screened for members with decreased serum growth. The results revealed that disruption of A. baumannii phospholipase D (PLD) caused a reduction in the organism's ability to thrive in serum, a deficiency in epithelial cell invasion, and diminished pathogenesis in a murine model of pneumonia. Collectively, these results suggest that PLD is an A. baumannii virulence factor.

Citing Articles

A chronic murine model of pulmonary infection enabling the investigation of late virulence factors, long-term antibiotic treatments, and polymicrobial infections.

Jackson-Litteken C, Di Venanzio G, Janet-Maitre M, Castro I, Mackel J, Rosen D bioRxiv. 2024; .

PMID: 39345519 PMC: 11429896. DOI: 10.1101/2024.09.17.613469.


Clinical and microbiological features of a cohort of patients with Acinetobacter baumannii bloodstream infections.

Wu C, Yuan Y, Tang S, Liu C, He C Eur J Clin Microbiol Infect Dis. 2024; 43(9):1721-1730.

PMID: 39023632 PMC: 11349859. DOI: 10.1007/s10096-024-04881-0.


Current treatment strategies for targeting virulence factors and biofilm formation in .

Rajangam S, Narasimhan M Future Microbiol. 2024; 19(10):941-961.

PMID: 38683166 PMC: 11290764. DOI: 10.2217/fmb-2023-0263.


Outer Membrane Vesicles from : Biogenesis, Functions, and Vaccine Application.

Weng Z, Yang N, Shi S, Xu Z, Chen Z, Liang C Vaccines (Basel). 2024; 12(1).

PMID: 38250862 PMC: 10818702. DOI: 10.3390/vaccines12010049.


Prevalence of ventilator-associated events and antibiogram of bacterial isolates of ventilator-associated pneumonia in a tertiary care hospital of Uttarakhand.

Kori A, Negi N, Chandola I, Roy R, Gairola S, Gaur L Iran J Microbiol. 2023; 15(6):765-770.

PMID: 38156309 PMC: 10751612. DOI: 10.18502/ijm.v15i6.14137.


References
1.
Doi Y, Husain S, Potoski B, McCurry K, Paterson D . Extensively drug-resistant Acinetobacter baumannii. Emerg Infect Dis. 2009; 15(6):980-2. PMC: 2727341. DOI: 10.3201/eid1506.081006. View

2.
Soucek A, MICHALEC C, Souckova A . Identification and characterization of a new enzyme of the group "phospholipase D" isolated from Corynebacterium ovis. Biochim Biophys Acta. 1971; 227(1):116-28. DOI: 10.1016/0005-2744(71)90173-2. View

3.
Maegele M, Gregor S, Steinhausen E, Bouillon B, Heiss M, Perbix W . The long-distance tertiary air transfer and care of tsunami victims: injury pattern and microbiological and psychological aspects. Crit Care Med. 2005; 33(5):1136-40. DOI: 10.1097/01.ccm.0000163269.42524.50. View

4.
Choi C, Lee J, Lee Y, Park T, Lee J . Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells. BMC Microbiol. 2008; 8:216. PMC: 2615016. DOI: 10.1186/1471-2180-8-216. View

5.
Siegel R . Emerging gram-negative antibiotic resistance: daunting challenges, declining sensitivities, and dire consequences. Respir Care. 2008; 53(4):471-9. View